Lemongrass extract shows potential benefitsNutritional Significance, Antimicrobial, Antioxidants, Anticancer, and Antiviral Activities of Lemongrass Leaves Extract and Its Application as Hepatoprotective Agent against CCl4-Induced Hepatic Injury in Rats.
Study focused on extract, not vitamin C
We explored the effects of lemongrass extract on liver health and cancer, with a focus on its nutritional properties and potential to help combat diseases like breast cancer. The study revealed that lemongrass extract is rich in bioactive components, including phenolic acids and flavonoids, which contribute to its powerful antioxidant activities.
While the extract showed an impressive ability to inhibit the growth of breast cancer cells by 81%, the specific impact of vitamin C within the lemongrass was not isolated or extensively detailed in this research. This indicates that while lemongrass extract may have positive effects against breast cancer, attributing those benefits solely to vitamin C would be unsubstantiated and misleading.
Furthermore, lemongrass extract demonstrated promising hepatoprotective qualities, reducing markers of liver damage in rats exposed to harmful substances. However, the study does not make claims about vitamin C's effectiveness independently as a treatment for breast cancer, and our findings should be interpreted in the context of the combined effects of various compounds in the extract. Overall, this research indicates a multifaceted approach to cancer treatment rather than a single focus on vitamin C alone.
Read More
Vitamin C and curcumin synergy exploredIn Silico and In Vitro Verification of the Effects of Chemotherapeutic Doxorubicin and 5-Fluorouracil in Combination With Curcumin and Vitamin C on MCF-7 Cells.
Moderate relevance to breast cancer
Our research aimed to understand how Vitamin C, when combined with curcumin and two common chemotherapy drugs—doxorubicin and 5-fluorouracil—affects MCF-7 breast cancer cells. We meticulously conducted both in silico analyses and in vitro experiments to evaluate the effectiveness of these combinations on cell viability and inflammation markers.
We discovered that the combination of Vitamin C with curcumin and chemotherapy did show some promising results, particularly in reducing cell viability by up to 28% after 24 hours. In our tests, curcumin and doxorubicin exhibited the strongest interaction with certain proteins involved in inflammation, whereas Vitamin C displayed moderate effects. Notably, the inflammatory marker IL-6 was significantly expressed in the presence of curcumin.
However, it's important to highlight that while Vitamin C showed some synergy with the chemotherapeutic agents in the context of inflammation, there wasn’t enough evidence to strongly confirm its isolated effectiveness in breast cancer treatment alone. Our findings indicate that Vitamin C, especially when paired with curcumin, offers potential benefits, but further research is needed to solidify its role in therapy.
Read More
Vitamin C may reduce breast cancerThe association between vitamin C and breast cancer, prostate cancer and colorectal cancer: A systematic review and meta-analysis.
Study highly relevant to topic.
We examined the relationship between vitamin C and breast cancer through a systematic review and meta-analysis of various studies. By analyzing data from both cohort and case-control studies, we aimed to ascertain how dietary vitamin C affects breast cancer risk.
Our findings reveal an interesting trend. While we found that dietary vitamin C consumption was inversely related to breast cancer risk in case-control studies, showing a significant reduction in breast cancer incidence, the results from cohort studies presented a pooled relative risk (RR) of 0.99. This indicates no substantial association in those comprehensive, long-term observations.
Moreover, our review highlighted that there was no notable connection between vitamin E and breast cancer, suggesting that more research is needed to understand the complete impact of these nutrients. Overall, while the case-control study results are promising, the cohort studies suggest that more nuanced insights might be necessary before making solid conclusions about vitamin C as a preventive measure against breast cancer.
Read More
We investigated how vitamin C might influence endometrial health in women with breast cancer. To do this, we measured endometrial thickness in both breast cancer patients and healthy controls using transvaginal ultrasound. We also established a mouse model with breast cancer tumors to observe the effects of vitamin C on uterine pathology.
Our research revealed that breast cancer patients and the tumor-bearing mice had a significantly lower endometrial thickness compared to healthy individuals. Interestingly, the presence of tumor-related oxidative stress led to changes in gene expression linked to the extracellular matrix and the process of epithelial-mesenchymal transition (EMT).
We found that vitamin C treatment helped reduce the damage in the endometrial tissue. It inhibited the EMT process and collagen buildup, thereby preserving the structure of the uterus in our tumor-bearing mice models. This suggests that vitamin C might be beneficial in addressing endometrial fibrosis, driven by oxidative stress in breast cancer patients.
Overall, our findings indicate that vitamin C can play a valuable role in managing endometrial complications linked to breast cancer, potentially impacting fertility preservation efforts for younger patients facing this diagnosis.
Read More
Vitamin C improves leukaemia treatmentTargeting the redox vulnerability of acute myeloid leukaemia cells with a combination of auranofin and vitamin C.
Score reflects limited vitamin C focus.
We explored the effects of auranofin (AUF) combined with vitamin C (VC) on leukaemia cells, particularly focusing on acute myeloid leukaemia (AML). This study found that the combination of AUF and VC was effective in killing leukaemic cell lines from various myeloid subtypes.
Early responses to the treatment included an increase in reactive oxygen species and a decrease in ATP levels, which led to a significant stop in protein synthesis. These changes suggest that the AUF and VC pairing may trigger cell death in leukaemic cells.
Moreover, the combination therapy appeared to be particularly effective in eliminating primary AML cells from many patients’ samples, with less toxicity observed in normal cells. This points to a potential therapeutic approach that could specifically exploit the redox vulnerabilities present in AML, making it an exciting area for future research.
Read More